血管性白塞病锁骨下动脉假性动脉瘤的血管内治疗修复：10年临床病程的病例报告
Subclavian artery pseudoaneurysm in vascular Behcet's disease repaired using endovascular treatment: A case report of the clinical course over 10 years.
作者信息
Abe Kaito, Uchida Koutarou, Sugano Teruyasu, Ishigami Tomoaki, Ishikawa Toshiyuki
机构信息
Department of Cardiology, Omori Red Cross Hospital, Tokyo, Japan.
Department of Medical Science and Cardio-Renal Medicine, Yokohama City University, Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ward, Yokohama 236-0004, Kanagawa, Japan.
出版信息
J Cardiol Cases. 2020 Dec 18;24(1):1-5. doi: 10.1016/j.jccase.2020.11.018. eCollection 2021 Jul.
The vascular involvement in patients with Behcet's disease is defined as vascular Behcet's disease, which can greatly influence the prognosis. However, there are few reports on endovascular treatment (EVT) for subclavian pseudoaneurysms with long-term prognosis over 10 years. We present the case of a 42-year-old man with left subclavian artery pseudoaneurysm due to vascular Behcet's disease who was treated with EVT along with immunosuppressive therapies. Subsequently, 8 years after, the aneurysm recurred in the stent with stent fracture. Therefore, additional EVT was performed. We present the details of the patient's clinical course over 10 years after the EVT. < Vascular Behcet's disease can greatly influence the prognosis. Therefore, understanding its treatment and management is important. There are few reports on endovascular treatment (EVT) for subclavian pseudoaneurysms with long-term prognosis over 10 years. Long-term management and recurrence monitoring are required for vascular Behcet's disease even after EVT.>.
白塞病患者的血管受累被定义为血管性白塞病，这会极大地影响预后。然而，关于锁骨下假性动脉瘤的血管内治疗（EVT）及超过10年长期预后的报道很少。我们报告一例42岁男性患者，因血管性白塞病导致左锁骨下动脉假性动脉瘤，接受了EVT及免疫抑制治疗。随后，8年后，动脉瘤在支架处复发并伴有支架断裂。因此，进行了额外的EVT。我们展示了该患者EVT后10年的临床病程细节。<血管性白塞病会极大地影响预后。因此，了解其治疗和管理很重要。关于锁骨下假性动脉瘤的血管内治疗（EVT）及超过10年长期预后的报道很少。即使在EVT后，血管性白塞病也需要长期管理和复发监测。>
Zotero 插件